Which of the following are assessment features for evaluating patient response to bronchodilator therapy?
I.reversibility of airflow obstruction
II.changes in flow rates using a peak flowmeter or portable spirometry
III.changes in vital signs
IV.changes in ventilation and oxygenation
V.the patient's subjective reaction to treatment
A) II, III, and IV
B) II, III, and V
C) I, II, III, and V
D) I, II, III, IV, and V
Correct Answer:
Verified
Q23: Long-acting adrenergic bronchodilators such as salmeterol (Serevent)
Q24: What are some potential adverse effects
Q25: What is the dosage for ipratropium bromide
Q26: What is the average duration of action
Q27: Which of the following is NOT
Q29: Which of the following short-acting noncathecholamine agents
Q30: Ipratropium bromide (Atrovent) is indicated for maintenance
Q31: What is the name of the enzyme
Q32: Short-acting adrenergic bronchodilators are considered what type
Q33: What amount of ipratropium bromide (Atrovent)
Unlock this Answer For Free Now!
View this answer and more for free by performing one of the following actions
Scan the QR code to install the App and get 2 free unlocks
Unlock quizzes for free by uploading documents